Antibodies to cardiolipin may increase the risk of failure of peripheral vein bypasses

European Journal of Vascular and Endovascular Surgery

Volumn 14, Issue 3, 1997, Pages 177-184

  Nielsen, T G ^a   Nordestgaard, B G ^a   Von Jessen, F ^a   Andreasen, J J ^a   Wiik, A ^a   Heegaard, N H H ^a   Schroeder, T V ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Doppler; Duplex; Graft occlusion; Saphenous vein; Transplantation; Ultrasonography; Vascular

Indexed keywords

CARBOXYHEMOGLOBIN; CARDIOLIPIN ANTIBODY; LIPID;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE MEASUREMENT; DIABETES MELLITUS; FEMALE; HEMOSTASIS; HUMAN; INGUINAL REGION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VEIN; PRIORITY JOURNAL; REGRESSION ANALYSIS; STENOSIS; TREATMENT FAILURE; VEIN BYPASS; VEIN GRAFT; VEIN THROMBOSIS;

EID: 0030801165     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-5884(97)80188-8     Document Type: Article

References (49)

1. Leather RP Shah DM Chang BB Kaufman JL Resurrection of the in situ saphenous vein bypass. 1000 cases later Ann Surg 208 1988 435 442
2. Veith FJ Gupta SK Ascer E Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetraflouroethylene grafts in infrainguinal arterial reconstructions J Vasc Surg 3 1986 104 114
3. Jensen LP Schroeder TV Lorentzen JE In situ saphenous vein bypass surgery in diabetic patients Eur J Vasc Surg 6 1992 533 539
4. Whittemore AD Clowes AW Couch NP Mannick JA Secondary femoropopliteal reconstruction Ann Surg 193 1981 35 42
5. Davies MG Hagen PO Pathophysiology of vein graft failure: a review Eur J Vasc Endovasc Surg 9 1995 7 18
6. Varty K Allen KE Bell PRF London NJM Infrainguinal vein graft stenosis Br J Surg 80 1993 825 833
7. Moody P de Cossart LM Douglas HM Harris PL Asymptomatic strictures in femoropopliteal vein grafts Eur J Vasc Surg 3 1989 389 392
8. Szilagyi DE Elliott JP Hageman JH Smith RF Dall'Olmo CA Biological fate of autogenous vein implants as arterial substitutes Ann Surg 178 1973 232 246
9. Nielsen TG Natural history of infrainguinal vein bypass stenoses: early lesions increase the risk of thrombosis Eur J Vasc Endovasc Surg 12 1996 60 64
10. Sayers RD Jones L Varty K The histopathology of infrainguinal vein graft stenoses Eur J Vasc Surg 7 1993 16 20
11. Sottiurai VS Yao JST Flinn WR Batson RC Intimal hyperplasia and neointima: an ultrastructural analysis of thrombosed grafts in humans Surgery 93 1983 809 817
12. Marin ML Veith FJ Gordon RE Analysis of balloon dilatation of human vein graft stenoses Ann Vasc Surg 7 1993 2 7
13. Ip JH Fuster V Badimon L Badimon J Taubman MB Chesebro JH Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation J Am Coll Cardiol 15 1990 1667 1687
14. Marin ML Veith FJ Panetta TF Saphenous vein biopsy: a predictor of vein graft failure J Vasc Surg 18 1993 407 415
15. Davies AH Magee TR Baird RN Sheffield E Horrocks M Pre-bypass morphological changes in vein grafts Eur J Vasc Surg 7 1993 642 647
16. Hoff HF Beck GJ Skibinski CI Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients Circulation 77 1988 1238 1244
17. Morton KE Gavaghan TP Krilis SA Coronary artery bypass graft failure — an autoimmune phenomenon? Lancet ii 1986 1353 1357
18. Colyvas N Rapp JH Philips NR Relation of plasma lipid and apoprotein levels to progressive intimal hyperplasia after arterial endarterectomy Circulation 85 1992 1286 1292
19. Cuming R Worrell P Woolcock NE Franks PJ Greenhalgh RM Powell JT The influence of smoking and lipids on restenosis after carotid endarterectomy Eur J Vasc Surg 7 1993 572 576
20. Wiseman S Kenchington G Dain R Marshall CE McCollum CN Greenhalgh RM Powell JT Influence of smoking and plasma factors on patency of femoropopliteal vein grafts Br Med J 299 1989 643 646
21. Wiseman S Powell J Greenhalgh R The influence of smoking and plasma factors on prosthetic graft patency Eur J Vasc Surg 4 1990 57 61
22. Donaldson MC Weinberg DS Belkin M Whittemore AD Mannick JA Screening for hypercoagulable states in vascular surgical practice: a preliminary study J Vasc Surg 11 1990 825 831
23. Mouritsen S Høier-Madsen M Wiik A Ørum O Pedersen SN The specificity of anti-cardiolipin antibodies from syfilis patients and from patients with systemic lupus erythematosus Clin Exp Immunol 76 1989 178 183
24. Loizou S McCrea JD Rudge AC Reynolds R Boyle CC Harris EN Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantification of results Clin Exp Immunol 62 1985 738 745
25. Vaarala O Alfthan G Jauhiainen M Leirisalo-Repo M Aho K Palosuo T Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus Lancet 341 1993 923 925
26. Palinski W Ylä-Herttuala S Rosenfeld ME Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein Arteriosclerosis 10 1990 325 335
27. Petersen LC Handest P Brender J Selmer J Jørgensen M Thorsen S A sensitive solid-phase immunosorbent assay for tissue-type plasminogen activator activity in plasma using trinitrobenzoylated poly-D-lysine as a stimulator for plasminogen activation Thromb Haemostas 57 1987 205 211
28. Philips M Juul AG Selmer J Lind B Thorsen S A specific immunologic assay for functional plasminogen activator inhibitor 1 in plasma — standardized measurements of the inhibitor and related parameters in patients with venous thromboembolic disease Thromb Haemostas 68 1992 486 494
29. Altman DG Sample size Altman DG Practical statistics for medical research 1991 Chapman & Hall London 455 460
30. Hughes GR The antiphospholipid syndrome: ten years on Lancet 342 1993 341 344
31. Derksen RHWM de Groot PG Kater L Anti-phospholipid antibodies and vascular pathology Neth J Med 45 1994 257 261
32. McNeil HP Hunt JE Krilis SA Antiphospholipid antibodies — new insights into their specificity and clinical importance (editorial) Scand J Immunol 36 1992 647 652
33. Shortell CK Ouriel K Green RM Condemi JJ DeWeese JA Vascular disease in the antiphospholipid syndrome: a comparison with the patient population with atherosclerosis J Vasc Surg 15 1992 158 166
34. Lockshin MD Antiphospholipid antibody syndrome JAMA 268 1992 1451 1453
35. Roubey RAS Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other “antiphospholipid” autoantibodies Blood 84 1994 2854 2867
36. Ciocca RG Choi J Graham AM Antiphospholipid antibodies lead to increased risk in cardiovascular surgery Am J Surg 170 1995 198 200
37. Prieto LN Suki WN Frequent hemodialysis graft thrombosis: association with antiphospholipid antibodies Am J Kidney Dis 23 1994 587 590
38. Taylor LM Chitwood RW Dalman RL Sexton G Goodnight SH Porter JM Antiphospholipid antibodies in vascular surgery patients Ann Surg 220 1994 544 551
39. Fligelstone LJ Cachia PG Ralis H Lupus anticoagulant in patients with peripheral vascular disease: a prospective study Eur J Vasc Endovasc Surg 9 1995 277 283
40. Khamashta MA Cuadrado MJ Mujic F The management of thrombosis in the antiphospholipid-antibody syndrome N Engl J Med 332 1995 993 997
41. Eldrup-Jorgensen J Flanigan DP Brace L Hypercoagulable states and lower limb ischemia in young adults J Vasc Surg 9 1989 334 341
42. Cheshire NJW Wolfe JHN Barradas MA Chambler AW Mikhailidis DP Smoking and plasma fibrinogen, lipoprotein (a) and serotonin are markers for postoperative infrainguinal graft stenosis Eur J Vasc Endovasc Surg 11 1996 479 486
43. Hicks RCJ Ellis M Mir-Hasseine R The influence of fibrinogen concentration on the development of vein graft stenoses Eur J Vasc Endovasc Surg 9 1995 415 420
44. Zilversmit DB Atherogenesis: a postprandial phenomenon Circulation 60 1979 473 485
45. Zenker G Költringer P Boné G Niederkorn K Pfeiffer K Jürgens G Lipoprotein(a) as a strong indicator for cerebrovascular disease Stroke 17 1986 942 945
46. Widmann MD Sumpio BE Lipoprotein (a): a risk factor for peripheral vascular disease Ann Vasc Surg 7 1993 446 451
47. Salenius JP Haapanen A Harju E Jokela H Riekkinen H Late carotid restenosis: aetiologic factors for recurrent carotid artery stenosis during long-term follow-up Eur J Vasc Surg 3 1989 271 277
48. Antibodies to oxidised LDL in atherosclerosis (editorial) Lancet 339 1992 899 900
49. Salonen JT Ylä-Herttuala S Yamamoto R Autoantibody against oxidised LDL and progression of carotid atherosclerosis Lancet 339 1992 883 887